NATCOPHARM.NS
NATCO Pharma Limited$893.40
Jun 05, 2026
Market cap
$160.02B
52w range
—
P / E
—
EPS · FY 2026
$79.21
Volume
—
Revenue · FY 2026
$40.78B
Explain this page
Arphra AIPlain-English read on NATCO Pharma Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,764.59
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Cyclical+1.83%
- Real Estate+1.51%
- Consumer Defensive+1.04%
- Financial Services+0.64%
- Healthcare+0.23%
- Communication Services-0.05%
- Industrials-0.48%
- Basic Materials-0.52%
- Utilities-1.51%
- Technology-1.52%
- Energy-1.72%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.07%
- Solar-6.69%
- Computer Hardware-5.87%
- Investment - Banking & Investment Services-5.29%
- Hardware, Equipment & Parts-4.81%
- Silver-4.57%
- Engineering & Construction-4.05%
- Software - Infrastructure-3.87%
- Financial - Capital Markets-3.83%
- Oil & Gas Drilling-3.76%
- Gold-3.54%
- Other Precious Metals-3.48%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for NATCOPHARM.NS.
Peers
No peer list available for NATCOPHARM.NS.
Total assets
$110.74B
Total debt
$7.14B
Cash & equiv
$1.99B
Operating CF
$17.68B
Free cash flow
$13.77B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $40.78B | $12.3B | $14.19B | $79.21 | +34.78% |